Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides
Authors:
- 17 April 2010
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 88 (7) , 719-727
Abstract
Autoantibodies to ribosomal P (ribo P) are found in 15–30% of systemic lupus erythematosus (SLE) patients and are highly specific for SLE. The goal of this study is to assess the temporal association of anti-ribosomal P (anti-P) responses with SLE disease onset, as well as to characterize select humoral ribo P epitopes targeted in early, pre-diagnostic SLE samples. Patients with stored serial serum samples available prior to SLE diagnosis were identified from a military cohort. Each sample was tested for antibodies against ribo P utilizing standard C terminus ribo P enzyme-linked immunosorbent assays (ELISA) and a solid phase, bead-based assay with affinity-purified ribo P proteins. In this study, antibodies to ribo P were more common in African American SLE patients (p = 0.026), and anti-P-positive patients comprised a group with more measured autoantibody specificities than did other SLE patients (3.5 vs 2.2, p < 0.05). Antibodies against ribo P were present on average 1.7 years before SLE diagnosis and were detected an average of 1.08 years earlier in pre-diagnostic SLE samples using affinity-purified whole protein rather than C-terminal peptide alone (p = 0.0019). Furthermore, 61% of anti-P-positive patients initially had antibodies to aa 99–113, a known ribosomal P0 antigenic target, at a time point when no antibodies to the clinically used C terminus were detected. Our findings provide evidence that antibodies against ribosomal P frequently develop before clinical SLE diagnosis and are more broadly reactive than previously thought by targeting regions outside of the C terminus.Keywords
This publication has 32 references indexed in Scilit:
- Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2009
- Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort studyJournal of Autoimmunity, 2009
- Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosusClinical Rheumatology, 2008
- Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysisArthritis & Rheumatism, 2005
- Humoral Antigenic Targets of the Ribosomal P0 Lupus Autoantigen Are Not Limited to the Carboxyl RegionAnnals of the New York Academy of Sciences, 2005
- Anti-ribosomal P protein antibodiesAutoimmunity, 2005
- Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodiesAnnals of the Rheumatic Diseases, 2000
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The Effect of Phosphorylation and Site-Specific Mutations in the Immunodominant Epitope of the Human Ribosomal P ProteinsClinical Immunology and Immunopathology, 1994
- Association between Lupus Psychosis and Antiribosomal P Protein AntibodiesNew England Journal of Medicine, 1987